259 related articles for article (PubMed ID: 10076538)
21. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
22. Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells.
de-Mello MA; Flodström M; Eizirik DL
Biochem Pharmacol; 1996 Dec; 52(11):1703-9. PubMed ID: 8986132
[TBL] [Abstract][Full Text] [Related]
23. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
[TBL] [Abstract][Full Text] [Related]
24. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage.
Scarim AL; Nishimoto SY; Weber SM; Corbett JA
Endocrinology; 2003 Aug; 144(8):3415-22. PubMed ID: 12865320
[TBL] [Abstract][Full Text] [Related]
25. Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1 beta-induced inhibition of glucose metabolism in rat pancreatic islets.
Welsh N; Margulis B; Bendtzen K; Sandler S
J Endocrinol; 1994 Oct; 143(1):151-6. PubMed ID: 7964313
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans.
Corbett JA; Kwon G; Misko TP; Rodi CP; McDaniel ML
Am J Physiol; 1994 Jul; 267(1 Pt 1):C48-54. PubMed ID: 7519400
[TBL] [Abstract][Full Text] [Related]
29. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.
Reimers JI; Andersen HU; Mauricio D; Pociot F; Karlsen AE; Petersen JS; Mandrup-Poulsen T; Nerup J
Diabetes; 1996 Jun; 45(6):771-8. PubMed ID: 8635652
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
31. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta.
Ye J; Laychock SG
Endocrinology; 1998 Oct; 139(10):4155-63. PubMed ID: 9751495
[TBL] [Abstract][Full Text] [Related]
32. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells.
Azevedo-Martins AK; Lortz S; Lenzen S; Curi R; Eizirik DL; Tiedge M
Diabetes; 2003 Jan; 52(1):93-101. PubMed ID: 12502498
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta 1 prevents cytokine-mediated inhibitory effects and induction of nitric oxide synthase in the RINm5F insulin-containing beta-cell line.
Mabley JG; Cunningham JM; John N; Di Matteo MA; Green IC
J Endocrinol; 1997 Dec; 155(3):567-75. PubMed ID: 9488002
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 1-induced Fos and Jun do not regulate inducible nitric oxide synthase in rat islets of Langerhans and RINm5F cells.
Kwon G; Corbett JA; McDaniel ML
Endocrinology; 1996 Mar; 137(3):825-30. PubMed ID: 8603591
[TBL] [Abstract][Full Text] [Related]
35. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
36. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
Corbett JA; McDaniel ML
J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
Sandler S; Sternesjö J
Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1.
Sandler S; Welsh N
Biochem Biophys Res Commun; 1993 Sep; 195(2):859-65. PubMed ID: 8373422
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
